Literature DB >> 18288205

Mutant Huntingtin reduces HSP70 expression through the sequestration of NF-Y transcription factor.

Tomoyuki Yamanaka1, Haruko Miyazaki, Fumitaka Oyama, Masaru Kurosawa, Chika Washizu, Hiroshi Doi, Nobuyuki Nukina.   

Abstract

In Huntington's disease (HD), mutant Huntingtin, which contains expanded polyglutamine stretches, forms nuclear aggregates in neurons. The interactions of several transcriptional factors with mutant Huntingtin, as well as altered expression of many genes in HD models, imply the involvement of transcriptional dysregulation in the HD pathological process. The precise mechanism remains obscure, however. Here, we show that mutant Huntingtin aggregates interact with the components of the NF-Y transcriptional factor in vitro and in HD model mouse brain. An electrophoretic mobility shift assay using HD model mouse brain lysates showed reduction in NF-Y binding to the promoter region of HSP70, one of the NF-Y targets. RT-PCR analysis revealed reduced HSP70 expression in these brains. We further clarified the importance of NF-Y for HSP70 transcription in cultured neurons. These data indicate that mutant Huntingtin sequesters NF-Y, leading to the reduction of HSP70 gene expression in HD model mice brain. Because suppressive roles of HSP70 on the HD pathological process have been shown in several HD models, NF-Y could be an important target of mutant Huntingtin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18288205      PMCID: PMC2274932          DOI: 10.1038/emboj.2008.23

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  61 in total

1.  HSP-CBF is an NF-Y-dependent coactivator of the heat shock promoters CCAAT boxes.

Authors:  C Imbriano; F Bolognese; A Gurtner; G Piaggio; R Mantovani
Journal:  J Biol Chem       Date:  2001-04-16       Impact factor: 5.157

2.  Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.

Authors:  F C Nucifora ; M Sasaki; M F Peters; H Huang; J K Cooper; M Yamada; H Takahashi; S Tsuji; J Troncoso; V L Dawson; T M Dawson; C A Ross
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

3.  The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.

Authors:  J S Steffan; A Kazantsev; O Spasic-Boskovic; M Greenwald; Y Z Zhu; H Gohler; E E Wanker; G P Bates; D E Housman; L M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 4.  Transcriptional dysregulation in Huntington's disease.

Authors:  J H Cha
Journal:  Trends Neurosci       Date:  2000-09       Impact factor: 13.837

5.  Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila.

Authors:  H Y Chan; J M Warrick; G L Gray-Board; H L Paulson; N M Bonini
Journal:  Hum Mol Genet       Date:  2000-11-22       Impact factor: 6.150

6.  Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils.

Authors:  P J Muchowski; G Schaffar; A Sittler; E E Wanker; M K Hayer-Hartl; F U Hartl
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

7.  Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B.

Authors:  G Wang; N Sawai; S Kotliarova; I Kanazawa; N Nukina
Journal:  Hum Mol Genet       Date:  2000-07-22       Impact factor: 6.150

8.  Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity.

Authors:  N R Jana; M Tanaka; G h Wang; N Nukina
Journal:  Hum Mol Genet       Date:  2000-08-12       Impact factor: 6.150

9.  The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis.

Authors:  S Holbert; I Denghien; T Kiechle; A Rosenblatt; C Wellington; M R Hayden; R L Margolis; C A Ross; J Dausset; R J Ferrante; C Néri
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

10.  Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression.

Authors:  S T Suhr; M C Senut; J P Whitelegge; K F Faull; D B Cuizon; F H Gage
Journal:  J Cell Biol       Date:  2001-04-16       Impact factor: 10.539

View more
  55 in total

1.  Inhibition of Aggregation of Mutant Huntingtin by Nucleic Acid Aptamers In Vitro and in a Yeast Model of Huntington's Disease.

Authors:  Rajeev K Chaudhary; Kinjal A Patel; Milan K Patel; Radha H Joshi; Ipsita Roy
Journal:  Mol Ther       Date:  2015-08-27       Impact factor: 11.454

Review 2.  Targeting Hsp70 facilitated protein quality control for treatment of polyglutamine diseases.

Authors:  Amanda K Davis; William B Pratt; Andrew P Lieberman; Yoichi Osawa
Journal:  Cell Mol Life Sci       Date:  2019-09-24       Impact factor: 9.261

3.  Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunction.

Authors:  Tomoyuki Yamanaka; Asako Tosaki; Haruko Miyazaki; Masaru Kurosawa; Yoshiaki Furukawa; Mizuki Yamada; Nobuyuki Nukina
Journal:  Hum Mol Genet       Date:  2010-02-25       Impact factor: 6.150

Review 4.  NF-Y (CBF) regulation in specific cell types and mouse models.

Authors:  Sankar N Maity
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2016-11-02       Impact factor: 4.490

5.  Planar cell polarity gene Fuz triggers apoptosis in neurodegenerative disease models.

Authors:  Zhefan Stephen Chen; Li Li; Shaohong Peng; Francis M Chen; Qian Zhang; Ying An; Xiao Lin; Wen Li; Alex Chun Koon; Ting-Fung Chan; Kwok-Fai Lau; Jacky Chi Ki Ngo; Wing Tak Wong; Kin Ming Kwan; Ho Yin Edwin Chan
Journal:  EMBO Rep       Date:  2018-07-19       Impact factor: 8.807

6.  FACS-array-based cell purification yields a specific transcriptome of striatal medium spiny neurons in a murine Huntington disease model.

Authors:  Haruko Miyazaki; Tomoyuki Yamanaka; Fumitaka Oyama; Yoshihiro Kino; Masaru Kurosawa; Mizuki Yamada-Kurosawa; Risa Yamano; Tomomi Shimogori; Nobutaka Hattori; Nobuyuki Nukina
Journal:  J Biol Chem       Date:  2020-06-04       Impact factor: 5.157

Review 7.  Misfolded proteins recognition strategies of E3 ubiquitin ligases and neurodegenerative diseases.

Authors:  Deepak Chhangani; Nihar Ranjan Jana; Amit Mishra
Journal:  Mol Neurobiol       Date:  2012-09-22       Impact factor: 5.590

Review 8.  Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.

Authors:  Sara D Reis; Brígida R Pinho; Jorge M A Oliveira
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

9.  Intranuclear degradation of polyglutamine aggregates by the ubiquitin-proteasome system.

Authors:  Atsushi Iwata; Yu Nagashima; Lumine Matsumoto; Takahiro Suzuki; Tomoyuki Yamanaka; Hidetoshi Date; Ken Deoka; Nobuyuki Nukina; Shoji Tsuji
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

Review 10.  Mahogunin Ring Finger-1 (MGRN1), a Multifaceted Ubiquitin Ligase: Recent Unraveling of Neurobiological Mechanisms.

Authors:  Arun Upadhyay; Ayeman Amanullah; Deepak Chhangani; Ribhav Mishra; Amit Prasad; Amit Mishra
Journal:  Mol Neurobiol       Date:  2015-08-09       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.